{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T03:07:12Z","timestamp":1767668832371,"version":"3.48.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Science and Technology Innovation Action Plan","award":["No.22YF1433000"],"award-info":[{"award-number":["No.22YF1433000"]}]},{"name":"Shanghai Science and Technology Innovation Action Plan","award":["No.22YF1433000"],"award-info":[{"award-number":["No.22YF1433000"]}]},{"name":"Shanghai Key Clinical Research Center Fund","award":["No. 2023ZZ02006"],"award-info":[{"award-number":["No. 2023ZZ02006"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.8220072419"],"award-info":[{"award-number":["No.8220072419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic scientific research project of Shanghai sixth people\u2019s hospital","award":["No.ynqn202215"],"award-info":[{"award-number":["No.ynqn202215"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03778-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T15:18:40Z","timestamp":1766416720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin-amplified ferroptosis induced by ultrasmall manganese ferrite nanoparticles: a GPX4-independent strategy for prostate cancer therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Zitong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongtong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3778_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946\u201367.","journal-title":"Cancer Cell"},{"key":"3778_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1200\/JCO.21.02530","volume":"40","author":"AK Morgans","year":"2022","unstructured":"Morgans AK, Beltran H. Isn\u2019t androgen deprivation enough? Optimal treatment for newly diagnosed metastatic prostate cancer. J Clin Oncol. 2022;40:818\u201324.","journal-title":"J Clin Oncol"},{"key":"3778_CR3","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3778_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277\u201388.","journal-title":"Nat Rev Cancer"},{"key":"3778_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"3778_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","volume":"21","author":"PHA Cao","year":"2024","unstructured":"Cao PHA, Dominic A, Lujan FE, Senthilkumar S, Bhattacharya PK, Frigo DE, et al. Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers. Nat Rev Urol. 2024;21:615\u201337.","journal-title":"Nat Rev Urol"},{"key":"3778_CR7","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1158\/1078-0432.CCR-20-3182","volume":"26","author":"J Bordini","year":"2020","unstructured":"Bordini J, Morisi F, Elia AR, Santambrogio P, Pagani A, Cucchiara V, et al. Iron induces cell death and strengthens the efficacy of antiandrogen therapy in prostate cancer models. Clin Cancer Res. 2020;26:6387\u201398.","journal-title":"Clin Cancer Res"},{"key":"3778_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02842-5","volume":"22","author":"S Han","year":"2024","unstructured":"Han S, Zou J, Xiao F, Xian J, Liu Z, Li M, et al. Nanobiotechnology boosts ferroptosis: opportunities and challenges. J Nanobiotechnol. 2024;22:606.","journal-title":"J Nanobiotechnol"},{"key":"3778_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31:e1904197.","journal-title":"Adv Mater"},{"key":"3778_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20:7\u201323.","journal-title":"Nat Rev Cardiol"},{"key":"3778_CR11","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1021\/cr300068p","volume":"112","author":"LH Reddy","year":"2012","unstructured":"Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112:5818\u201378.","journal-title":"Chem Rev"},{"key":"3778_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20\u201337.","journal-title":"Nat Rev Cancer"},{"key":"3778_CR13","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1021\/jacs.9b12873","volume":"142","author":"Y Sang","year":"2020","unstructured":"Sang Y, Cao F, Li W, Zhang L, You Y, Deng Q, et al. Bioinspired construction of a nanozyme-based H2O2 homeostasis disruptor for intensive chemodynamic therapy. J Am Chem Soc. 2020;142:5177\u201383.","journal-title":"J Am Chem Soc"},{"key":"3778_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612:338\u201346.","journal-title":"Nature"},{"key":"3778_CR15","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR, Jiang X. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748\u2013e27642722.","journal-title":"Cell"},{"key":"3778_CR16","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1039\/D3BM01894F","volume":"12","author":"M Huang","year":"2024","unstructured":"Huang M, Teng Q, Cao F, Huang J, Pang J. Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer. Biomater Sci. 2024;12:1617\u201329.","journal-title":"Biomater Sci"},{"key":"3778_CR17","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"3778_CR18","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1039\/D3CS00001J","volume":"52","author":"N Kang","year":"2023","unstructured":"Kang N, Son S, Min S, Hong H, Kim C, An J, et al. Stimuli-responsive ferroptosis for cancer therapy. Chem Soc Rev. 2023;52:3955\u201372.","journal-title":"Chem Soc Rev"},{"key":"3778_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cmet.2023.12.007","volume":"36","author":"L Guarente","year":"2024","unstructured":"Guarente L, Sinclair DA, Kroemer G. Human trials exploring anti-aging medicines. Cell Metab. 2024;36:354\u201376.","journal-title":"Cell Metab"},{"key":"3778_CR20","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/JCO.23.00296","volume":"41","author":"PJ Goodwin","year":"2023","unstructured":"Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, et al. Effect of metformin versus placebo on new primary cancers in Canadian cancer trials group MA.32: a secondary analysis of a phase III randomized double-blind trial in early breast cancer. J Clin Oncol. 2023;41:5356\u201362.","journal-title":"J Clin Oncol"},{"key":"3778_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20:953\u201366.","journal-title":"Cell Metab"},{"key":"3778_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","volume":"60","author":"BM Heckman-Stoddard","year":"2017","unstructured":"Heckman-Stoddard BM, DeCensi A, Sahasrabuddhe VV, Ford LG. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia. 2017;60:1639\u201347.","journal-title":"Diabetologia"},{"key":"3778_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol. 2023;19:460\u201376.","journal-title":"Nat Rev Endocrinol"},{"key":"3778_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","volume":"24","author":"X Liu","year":"2016","unstructured":"Liu X, Romero IL, Litchfield LM, Lengyel E, Locasale JW. Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers. Cell Metab. 2016;24:728\u201339.","journal-title":"Cell Metab"},{"key":"3778_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41391-024-00871-7","volume":"28","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang Q, Huang X. Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies. Prostate Cancer Prostatic Dis. 2025;28:210\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3778_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrd.2016.248","volume":"16","author":"BJ Crielaard","year":"2017","unstructured":"Crielaard BJ, Lammers T, Rivella S. Targeting iron metabolism in drug discovery and delivery. Nat Rev Drug Discov. 2017;16:400\u201323.","journal-title":"Nat Rev Drug Discov"},{"key":"3778_CR27","doi-asserted-by":"crossref","unstructured":"Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D\u2019Agostino R Jr., et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 2011;71:6728\u201337.","DOI":"10.1158\/0008-5472.CAN-11-1870"},{"key":"3778_CR28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.cell.2018.09.050","volume":"175","author":"B Stynen","year":"2018","unstructured":"Stynen B, Abd-Rabbo D, Kowarzyk J, Miller-Fleming L, Aulakh SK, Garneau P, Ralser M, Michnick SW. Changes of cell biochemical States are revealed in protein homomeric complex dynamics. Cell. 2018;175:1418\u2013e14291419.","journal-title":"Cell"},{"key":"3778_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, et al. Metformin induces ferroptosis by inhibiting ufmylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res. 2021;40:206.","journal-title":"J Exp Clin Cancer Res"},{"key":"3778_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02655-6","volume":"23","author":"C Deng","year":"2023","unstructured":"Deng C, Xiong L, Chen Y, Wu K, Wu J. Metformin induces ferroptosis through the Nrf2\/HO-1 signaling in lung cancer. BMC Pulm Med. 2023;23:360.","journal-title":"BMC Pulm Med"},{"key":"3778_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00424-8","volume":"8","author":"M Huo","year":"2017","unstructured":"Huo M, Wang L, Chen Y, Shi J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat Commun. 2017;8:357.","journal-title":"Nat Commun"},{"key":"3778_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.addr.2013.11.008","volume":"72","author":"I Lentacker","year":"2014","unstructured":"Lentacker I, De Cock I, Deckers R. De Smedt scand Moonen CTW: Understanding ultrasound induced sonoporation: definitions and underlying mechanisms. Adv Drug Deliver Rev. 2014;72:49\u201364.","journal-title":"Adv Drug Deliver Rev"},{"key":"3778_CR33","doi-asserted-by":"publisher","first-page":"2004670","DOI":"10.1002\/advs.202004670","volume":"8","author":"Z Meng","year":"2021","unstructured":"Meng Z, Zhang Y, Shen E, Li W, Wang Y, Sathiyamoorthy K, Gao W, M CK, Bai W, Hu B, et al. Marriage of Virus-Mimic surface topology and Microbubble-Assisted ultrasound for enhanced intratumor accumulation and improved cancer theranostics. Adv Sci (Weinh). 2021;8:2004670.","journal-title":"Adv Sci (Weinh)"},{"key":"3778_CR34","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.1021\/jacs.7b05559","volume":"139","author":"J Kim","year":"2017","unstructured":"Kim J, Cho HR, Jeon H, Kim D, Song C, Lee N, et al. Continuous O2-evolving MnFe2O4 nanoparticle-anchored mesoporous silica nanoparticles for efficient photodynamic therapy in hypoxic cancer. J Am Chem Soc. 2017;139:10992\u20135.","journal-title":"J Am Chem Soc"},{"key":"3778_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202413127","volume":"64","author":"L Chen","year":"2025","unstructured":"Chen L, Hu P, Fang W, Wu T, Shi J. Nebulized immunotherapy of orthotopic lung cancer by mild magnetothermal-based innate immunity activations. Angew Chem Int Ed Engl. 2025;64:e202413127.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"3778_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01885-4","volume":"21","author":"Q Qin","year":"2023","unstructured":"Qin Q, Zhou Y, Li P, Liu Y, Deng R, Tang R, et al. Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis. J Nanobiotechnol. 2023;21:131.","journal-title":"J Nanobiotechnol"},{"key":"3778_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01248-5","volume":"20","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shang W, Liu H, Hui H, Wu J, Zhang W, et al. Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer. J Nanobiotechnol. 2022;20:48.","journal-title":"J Nanobiotechnol"},{"key":"3778_CR38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.actbio.2024.04.032","volume":"181","author":"J Wang","year":"2024","unstructured":"Wang J, Wang Z, Li L, Wang M, Chang J, Gao M, et al. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy. Acta Biomater. 2024;181:362\u201374.","journal-title":"Acta Biomater"},{"key":"3778_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201905823","volume":"32","author":"B Ding","year":"2020","unstructured":"Ding B, Zheng P, Ma P, Lin J. Manganese oxide nanomaterials: synthesis, properties, and theranostic applications. Adv Mater. 2020;32:e1905823.","journal-title":"Adv Mater"},{"key":"3778_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"3778_CR41","doi-asserted-by":"publisher","first-page":"216155","DOI":"10.1016\/j.canlet.2023.216155","volume":"562","author":"G Wang","year":"2023","unstructured":"Wang G, Gao H, Dai S, Li M, Gao Y, Yin L, Zhang K, Zhang J, Jiang K. Miao Yand Lu Z: Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice. Cancer Lett. 2023;562:216155.","journal-title":"Cancer Lett"},{"key":"3778_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"3778_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"3778_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3778_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell. 2021;12:675\u20139.","journal-title":"Protein Cell"},{"key":"3778_CR46","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"3778_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146\u201362.","journal-title":"Cell Res"},{"key":"3778_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3778_CR49","doi-asserted-by":"publisher","first-page":"8230","DOI":"10.1021\/nn202912b","volume":"5","author":"HM Kim","year":"2011","unstructured":"Kim HM, Lee H, Hong KS, Cho MY, Sung MH, Poo H, et al. Synthesis and high performance of magnetofluorescent polyelectrolyte nanocomposites as MR\/near-infrared multimodal cellular imaging nanoprobes. ACS Nano. 2011;5:8230\u201340.","journal-title":"ACS Nano"},{"key":"3778_CR50","doi-asserted-by":"publisher","first-page":"e2304262","DOI":"10.1002\/adma.202304262","volume":"35","author":"B Tian","year":"2023","unstructured":"Tian B, Tian R, Liu S, Wang Y, Gai S, Xie Y, Yang D, He F, Yang P, Lin J. Doping engineering to modulate lattice and electronic structure for enhanced piezocatalytic therapy and ferroptosis. Adv Mater. 2023;35:e2304262.","journal-title":"Adv Mater"},{"key":"3778_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.actbio.2022.02.006","volume":"142","author":"G Zhang","year":"2022","unstructured":"Zhang G, Li N, Qi Y, Zhao Q, Zhan J, Yu D. Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatment and magnetic resonance imaging monitoring of pancreatic cancer. Acta Biomater. 2022;142:284\u201397.","journal-title":"Acta Biomater"},{"key":"3778_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114352","volume":"245","author":"M Liu","year":"2025","unstructured":"Liu M, Lu Y, Zhao J, Yin Y, Cao J, Wu L, et al. Artemisinin and salinomycin co-loaded nanozymes to boost cascade ROS accumulation for augmented tumor ferroptosis. Colloids Surf B Biointerfaces. 2025;245:114352.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3778_CR53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5:505\u201315.","journal-title":"Mol Pharm"},{"key":"3778_CR54","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0169-409X(02)00226-0","volume":"55","author":"H Otsuka","year":"2003","unstructured":"Otsuka H, Nagasaki Y, Kataoka K. Pegylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003;55:403\u201319.","journal-title":"Adv Drug Deliv Rev"},{"key":"3778_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114895","volume":"198","author":"P Wen","year":"2023","unstructured":"Wen P, Ke W, Dirisala A, Toh K, Tanaka M, Li J. Stealth and pseudo-stealth nanocarriers. Adv Drug Deliv Rev. 2023;198:114895.","journal-title":"Adv Drug Deliv Rev"},{"key":"3778_CR56","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/CIRCULATIONAHA.123.066110","volume":"149","author":"F Zhang","year":"2024","unstructured":"Zhang F, Li K, Zhang W, Zhao Z, Chang F, Du J, et al. Ganglioside GM3 protects against abdominal aortic aneurysm by suppressing ferroptosis. Circulation. 2024;149:843\u201359.","journal-title":"Circulation"},{"key":"3778_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8:372.","journal-title":"Signal Transduct Target Ther"},{"key":"3778_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jare.2024.04.012","volume":"69","author":"Z Zou","year":"2025","unstructured":"Zou Z, Hu W, Kang F, Xu Z, Li Y, Zhang J, et al. Interplay between lipid dysregulation and ferroptosis in chondrocytes and the targeted therapy effect of Metformin on osteoarthritis. J Adv Res. 2025;69:515\u201329.","journal-title":"J Adv Res"},{"key":"3778_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115835","volume":"168","author":"Y Sun","year":"2023","unstructured":"Sun Y, Bai YP, Wang DG, Xing YJ, Zhang T, Wang W, et al. Protective effects of metformin on pancreatic \u03b2-cell ferroptosis in type 2 diabetes in vivo. Biomed Pharmacother. 2023;168:115835.","journal-title":"Biomed Pharmacother"},{"key":"3778_CR60","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPX4. Free Radic Biol Med. 2020;152:175\u201385.","journal-title":"Free Radic Biol Med"},{"key":"3778_CR61","doi-asserted-by":"crossref","unstructured":"Ahola Sand Langer T. Ferroptosis in mitochondrial cardiomyopathy. Trends Cell Biol. 2024;34:150\u201360.","DOI":"10.1016\/j.tcb.2023.06.002"},{"key":"3778_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305895","volume":"11","author":"Q Lv","year":"2024","unstructured":"Lv Q, Lin J, Huang H, Ma B, Li W, Chen J, et al. Nanosponge for iron chelation and efflux: a Ferroptosis-inhibiting approach for myocardial infarction therapy. Adv Sci. 2024;11:e2305895.","journal-title":"Adv Sci"},{"key":"3778_CR63","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","volume":"12","author":"Y Xuan","year":"2022","unstructured":"Xuan Y, Wang H, Yung MM, Chen F, Chan WS, Chan YS, Tsui SK, Ngan HY. Chan KKand Chan DW: SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. Theranostics. 2022;12:3534\u201352.","journal-title":"Theranostics"},{"key":"3778_CR64","doi-asserted-by":"crossref","unstructured":"Liu Z, Huang T, Hong Y, Yang Y, Chen W, Zeng Q, Chen Q, Yang Y, Ying X, Zeng W, Wu Z, Zhao T, Wan X, Chen J. Ai Kand Huang Q: adaptive antioxidant nanomedicines inhibit ferroptosis in renal tubular epithelial cells to alleviate diabetic kidney disease. Adv Sci (Weinh) 2025;12:e5168.","DOI":"10.1002\/advs.202505168"},{"key":"3778_CR65","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"3778_CR66","first-page":"16","volume":"17","author":"ME Kaighn","year":"1979","unstructured":"Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979;17:16\u201323.","journal-title":"Invest Urol"},{"key":"3778_CR67","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ncb2122","volume":"12","author":"JW Astin","year":"2010","unstructured":"Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D. Oxley JDand Nobes CD: competition amongst Eph receptors regulates contact Inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol. 2010;12:1194\u2013204.","journal-title":"Nat Cell Biol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03778-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03778-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03778-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T03:02:33Z","timestamp":1767668553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03778-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03778-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"type":"electronic","value":"1477-3155"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal operations conformed to the guidelines of the Animal Care Ethics Commission of Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Animal Welfare Ethics (Acceptance No: DWLL2024\u20131063)).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}